2SLICHTER S J,DAVIS K,ENRIGHT H,et al.Factors affecting posttransfusion platelet increments,platelet refractoriness,and platelet transfusion intervals in thrombocytopenic patients[J].Blood,2005,105:4106-4114.
3REBULLA P.Refractoriness to platelet transfusion[J].Curr Opin Hematol,2002,9:516-520.
4THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS STUDY GROUP.Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.The Trial to Reduce Alloimmunization to Platelets Study Group.N Engl J Med,1997,337:1861-1869.
5SEFTEL M D,GROWE G H,PETRASZKO T,et al.Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness[J].Blood,2004,103:333-339.
6KIEFEL V,KONIG C,KROLL H,et al.Platelet alloantibodies in transfused patients[J].Transfusion,2001,41:766-770.
7SAITO S,OTA S,SESHIMO H,et al.Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens[J].Transfusion,2002,42:302-308.
9BLUMBERG N,HEAL J M,ROWE J M.A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia[J].BMC Blood Disord,2004,4:6-6.
10SCHIFFER C A,ANDERSON K C,BENNETT C L,et al.Platelet transfusion for patients with cancer:clinical practice guidelines of the American Society of Clinical Oncology[J].J Clin Oncol,2001,19:1519-1538.
